MedCap AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0009160872
SEK
544.00
112 (25.93%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
501.50
521.70
493.80
474.20
413.10
457.70
461.70
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
501.50
521.70
493.80
474.20
413.10
457.70
461.70
Raw Material Cost
430.10
442.80
424.60
424.20
358.20
391.80
387.80
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
125.60
136.30
129.70
126.50
102.70
121.80
113.80
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
7.60
6.90
4.60
4.80
4.30
5.80
4.30
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
-13.32
-14.32
-13.43
-13.13
-10.70
-12.76
-11.81
Total Expenditure (Excl Depreciation)
430.10
442.80
424.60
424.20
358.20
391.80
387.80
Operating Profit (PBDIT) excl Other Income
71.39999999999999
78.89999999999999
69.2
50
54.900000000000006
65.9
73.89999999999999
Other Income
4.60
2.50
4.70
8.40
14.60
12.40
2.40
Operating Profit (PBDIT)
111.40
115.50
106.30
88.30
99.10
105.90
104.50
Interest
7.60
6.90
4.60
4.80
4.30
5.80
4.30
Exceptional Items
0.00
-4.00
-3.80
-0.80
0.00
0.00
-0.40
Gross Profit (PBDT)
71.40
78.90
69.20
50.00
54.90
65.90
73.90
Depreciation
35.40
34.10
32.40
29.90
29.60
27.60
28.20
Profit Before Tax
68.50
70.40
65.40
52.80
64.90
72.40
71.60
Tax
17.30
16.70
14.70
10.10
11.60
15.30
15.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
51.20
53.60
50.50
41.50
52.90
56.80
56.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
51.20
53.60
50.50
41.50
52.90
56.80
56.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.10
0.10
0.20
1.20
0.40
0.30
0.10
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
51.30
53.70
50.70
42.70
53.30
57.10
56.10
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.4
0.4
0.4
0.4
0.4
0.4
0.4
Reserves
1,399.60
1,356.40
1,306.30
1,282.00
1,193.10
1,147.50
1,093.50
Earnings per share (EPS)
3.41
3.57
3.37
2.8
3.54
3.8
3.76
Diluted Earnings per share
3.41
3.57
3.37
2.8
3.54
3.8
3.76
Operating Profit Margin (Excl OI)
14.24%
15.12%
14.01%
10.54%
13.29%
14.4%
16.01%
Gross Profit Margin
20.72%
20.03%
19.81%
17.44%
22.88%
21.85%
21.62%
PAT Margin
10.21%
10.27%
10.23%
8.75%
12.81%
12.41%
12.13%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 21.40% vs 13.33% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is -3.75% vs 38.80% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 26.39% vs 5.76% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is 76.74% vs 10.26% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of MedCap AB With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Net Sales
501.50
209.16
292.34
139.77%
Other Operating Income
0.00
0.00
0.00
Total Operating income
501.50
209.16
292.34
139.77%
Raw Material Cost
430.10
92.40
337.70
365.48%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
125.60
0.00
125.60
Power Cost
0
0
0.00
Manufacturing Expenses
7.60
0.00
7.60
Selling and Distribution Expenses
0.00
69.53
-69.53
-100.00%
Other Expenses
-13.32
4.42
-17.74
-401.36%
Total Expenditure (Excl Depreciation)
430.10
206.16
223.94
108.62%
Operating Profit (PBDIT) excl Other Income
71.40
3.00
68.40
2,280.00%
Other Income
4.60
-21.71
26.31
121.19%
Operating Profit (PBDIT)
111.40
1.52
109.88
7,228.95%
Interest
7.60
0.00
7.60
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
71.40
116.75
-45.35
-38.84%
Depreciation
35.40
20.24
15.16
74.90%
Profit Before Tax
68.50
-18.72
87.22
465.92%
Tax
17.30
1.36
15.94
1,172.06%
Provisions and contingencies
0
0
0.00
Profit After Tax
51.20
-20.08
71.28
354.98%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
51.20
-20.08
71.28
354.98%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.10
0.00
0.10
Other related items
0.00
0.00
0.00
Consolidated Net Profit
51.30
-20.08
71.38
355.48%
Equity Capital
0
0
0.00
Face Value
0.40
0.05
0.00
Reserves
1,399.60
4,307.45
-2,907.85
-67.51%
Earnings per share (EPS)
3.41
-0.39
3.80
974.36%
Diluted Earnings per share
3.41
-0.39
3.80
974.36%
Operating Profit Margin (Excl OI)
14.24%
1.43%
0.00
12.81%
Gross Profit Margin
20.72%
0.73%
0.00
19.99%
PAT Margin
10.21%
-9.60%
0.00
19.81%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 50.15 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -3.87% vs 5.65% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 21.40% vs 13.33% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.13 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -4.47% vs 5.92% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -3.75% vs 38.80% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.68 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -5.49% vs 11.22% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 26.39% vs 5.76% in Sep 2024

Quarterly - Interest
Interest 0.76 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 10.14% vs 50.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 76.74% vs 10.26% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.24%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024